Results 191 to 200 of about 3,628 (221)

Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect

Thrombosis Research, 2008
Steve Steinhubl, Julie H Oestreich
exaly  

Cangrelor tetrasodium

Drugs of the Future, 2008
null Diaz-Ricart, M., null Escolar, G., null Serradell, N., null Rosa, E., null Bolos, J.   +4 more
openaire   +1 more source

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials

Journal of Thrombosis and Thrombolysis, 2012
Dominick J Angiolillo, David J Schneider, Deepak L Bhatt   +2 more
exaly  

Pharmacodynamic Effects During the Transition Between Cangrelor and Ticagrelor

JACC: Cardiovascular Interventions, 2014
David J Schneider, Naveen Anand Seecheran   +1 more
exaly  

Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention

Circulation, 2016
Michelle L O'donoghue, Deepak L Bhatt, Gregg W Stone   +2 more
exaly  

Outcomes With Cangrelor Versus Clopidogrel on a Background of Bivalirudin

JACC: Cardiovascular Interventions, 2015
Harvey D White, Deepak L Bhatt, C Michael Gibson   +2 more
exaly  

Cangrelor/heparin

Reactions Weekly, 2020
openaire   +1 more source

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data

Lancet, The, 2013
Philippe Gabriel Steg, Deepak L Bhatt, Christian W Hamm   +2 more
exaly  

Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice

Molecular Immunology, 2020
Tianwei Zhan, Wei-Ping Zhang
exaly  

Cangrelor Tetrasodium

2021
openaire   +1 more source